THY1 and cancer: Recently, the expression of CD90, a well-known stem cell biomarker, has been associated with resistance to different chemotherapeutic agents (cisplatin, cytarabine, etoposide, and paclitaxel) in various cancer cells, including those derived from lung, pancreatic, and gastric cancers [33].